Wishlist
Compare
Subscribe
Login
Home Medicine
Shop
Page
About Us
Contact Us
FAQs
Terms Of Use
5-Fu/Leucovorin (2)
6-Mp-Containing Pediatric All Protocols (1)
7+3 (1)
7+3 + Midostaurin (2)
Abiraterone + Androgen-Deprivation Therapy (Adt) (10)
Abiraterone + Prednisone/Prednisolone (10)
Abvd (1)
Abvd Alternatives (1)
Abvd Variants (1)
Ac (3)
Ac-T (7)
Acalabrutinib + Obinutuzumab (4)
Acalabrutinib + Venetoclax (4)
Acalabrutinib Monotherapy (4)
Adjuvant Abemaciclib + Endocrine Therapy (2)
Adjuvant Endocrine Therapy (5)
Adjuvant Gist Therapy (0)
Adjuvant Ribociclib + Endocrine Therapy (1)
Adjuvant T-Dm1 After Neoadjuvant Therapy With Residual Disease (0)
All Maintenance (1)
All Regimens (0)
Alpelisib + Endocrine Therapy In Selected Breast Cancer Settings (1)
Alpelisib + Fulvestrant (1)
Anastrozole Monotherapy (3)
Androgen-Deprivation Regimens (2)
Apalutamide + Adt (1)
Apalutamide + Adt In Metastatic Hormone-Sensitive Disease (1)
Appetite-Supportive Care Protocols (3)
Atezolizumab + Bevacizumab (4)
Avelumab Maintenance After Platinum Chemotherapy In Urothelial Carcinoma (1)
Avelumab Monotherapy (1)
Azacitidine + Venetoclax (3)
Azacitidine Monotherapy (3)
Azacitidine-Based Aml/Mds Regimens (3)
Bendamustine + Rituximab (4)
Bendamustine + Rituximab (Br) (1)
Bendamustine-Based Lymphoma Regimens (1)
Bep (6)
Bicalutamide + Lhrh Agonist/Adt (1)
Bortezomib-Based Myeloma Regimens (3)
Bosutinib Monotherapy (0)
Braf-Targeted Colorectal Combinations (2)
Breast Cancer Anthracycline Regimens (1)
Cabazitaxel + Prednisone/Prednisolone (0)
Cabozantinib Monotherapy (3)
Capecitabine + Oxaliplatin Or Other Disease-Specific Combinations (3)
Capox + Bevacizumab (3)
Capox/Xelox (7)
Carboplatin + Gemcitabine (6)
Carboplatin + Pemetrexed (6)
Carboplatin + Pemetrexed + Pembrolizumab (0)
Carboplatin/Paclitaxel + Bevacizumab (4)
Carbotaxol (11)
Cetuximab + Radiation (2)
Chemoradiation (2)
Chemoradiation Regimens (4)
Chemotherapy + Dasatinib In Ph-Positive All (5)
Chemotherapy-Induced Nausea/Vomiting Prophylaxis (2)
Chop/R-Chop (3)
Cisplatin + Gemcitabine (4)
Cisplatin + Pemetrexed (4)
Cladribine Monotherapy (1)
Cmf (4)
Combination Antiemetic Regimens (2)
Combination Ar-Pathway Regimens (10)
Consolidation Regimens (1)
Consolidation/Maintenance-Related Flt3 Regimens (2)
Crizotinib Monotherapy (1)
Cybord (2)
Cybord/Vcd (3)
Cytoreduction Regimens (3)
Dacarbazine-Based Melanoma Regimens (1)
Dara-Rd (3)
Dara-Vrd (3)
Dasatinib Monotherapy (5)
Degarelix Monotherapy For Androgen Deprivation (0)
Dhap (4)
Disease-Specific Regimens (1)
Docetaxel + Adt (5)
Docetaxel + Ramucirumab (5)
Ec/Ec-T (1)
Endocrine Combinations (2)
Endocrine Therapy + Abemaciclib (2)
Endocrine Therapy Combinations (3)
Enzalutamide + Adt (0)
Enzalutamide Monotherapy Where Labeled (0)
Ep (2)
Erlotinib Monotherapy (5)
Everolimus + Endocrine Therapy (4)
Everolimus + Exemestane (4)
Exemestane + Everolimus (1)
Exemestane Monotherapy (1)
Fec/Fec-T (1)
Flag-Ida (1)
Flag-Ida Variants (1)
Folfiri (2)
Folfiri + Bevacizumab (4)
Folfiri + Cetuximab (2)
Folfirinox (6)
Folfox (6)
Folfox + Bevacizumab (4)
Folfox + Cetuximab (2)
Folfox-Like Combinations Are Not Paclitaxel Regimens (5)
Folfox-Like Combinations Are Not Standard Cisplatin Regimens (4)
Fulvestrant + Alpelisib (4)
Fulvestrant + Cdk4/6 Inhibitor (4)
Fulvestrant + Targeted Agents (4)
Gastric/Gej Her2 Regimens (6)
Gefitinib Monotherapy (3)
Gemcis/Cisgem (2)
Gemcitabine + Carboplatin (2)
Gemcitabine + Docetaxel (2)
Gemcitabine + Nab-Paclitaxel (2)
Goserelin + Tamoxifen/Aromatase Inhibitor (2)
Hairy Cell Leukemia Regimens (1)
Hidac (1)
Historically Used Hormonal Therapy (1)
Hormonal Therapy (3)
Hydroxyurea Monotherapy (3)
Hyper-Cvad (1)
Hyper-Cvad And Many Hematologic Regimens (2)
Hyper-Cvad Variants (4)
Ibrutinib + Bendamustine/Rituximab (0)
Ibrutinib + Rituximab (0)
Ibrutinib Monotherapy (0)
Imatinib Monotherapy (0)
Isa-Kd And Other Myeloma Combinations (1)
Kd (1)
Krd (1)
Lapatinib + Capecitabine (3)
Lapatinib + Trastuzumab (3)
Lenvatinib + Everolimus (0)
Lenvatinib + Pembrolizumab (0)
Lenvatinib Monotherapy (0)
Letrozole + Cdk4/6 Inhibitor (1)
Letrozole Monotherapy (1)
Leuprolide + Antiandrogen (2)
Leuprolide + Ar-Pathway Inhibitor (2)
Lymphoma Combinations (3)
Lymphoma/Leukemia Salvage (1)
Maintenance After Autologous Transplant (3)
Maintenance Combinations (0)
Maintenance In Ovarian Cancer (4)
Maintenance Rituximab (4)
Maintenance Temozolomide (3)
Melphalan/Prednisone/Thalidomide (0)
Metastatic Hr+/Her2- Endocrine Combinations (2)
Mopp (1)
Myeloma Combinations (0)
Myeloma Or Lymphoma Regimens In Selected Settings (0)
Nilotinib Monotherapy (2)
Nintedanib + Docetaxel (1)
Nivolumab + Cabozantinib (4)
Nivolumab + Chemotherapy (1)
Nivolumab + Ipilimumab (1)
Nivolumab + Relatlimab (1)
Not A Standard Contemporary First-Line Regimen In Most Major Guidelines (1)
Olaparib + Bevacizumab (7)
Olaparib + Endocrine Therapy In Selected Settings (7)
Olaparib Maintenance (7)
Older Combined Androgen Blockade Regimens (1)
Other Disease-Specific Combinations (4)
Other Disease-Specific Regimens (5)
Other Myeloma Combinations (6)
Ovarian Platinum Regimens (6)
Ovarian Suppression (2)
Ovarian Suppression + Tamoxifen (1)
Paclitaxel + Pembrolizumab (5)
Palbociclib + Fulvestrant (6)
Palbociclib + Letrozole (6)
Palbociclib + Trastuzumab ? Pertuzumab + Endocrine Therapy (6)
Pazopanib Monotherapy (0)
Pcv (1)
Pediatric All/Aml Combinations (0)
Pemetrexed Maintenance (0)
Ph-Positive Leukemia Regimens (0)
Platinum/Etoposide Regimens (2)
Platinum/Topotecan Regimens (0)
Pld + Bevacizumab (0)
Pld + Carboplatin (0)
Pomalidomide + Daratumumab + Dexamethasone (6)
Pomalidomide + Dexamethasone (6)
Post-Docetaxel Mcrpc Regimens (0)
Primary Prophylaxis After Myelosuppressive Chemotherapy (0)
R-Chop (4)
R-Chop Variants (3)
R-Cvp (4)
Radiotherapy-Induced Nausea Protocols (2)
Rd (3)
Regorafenib Monotherapy (2)
Relugolix + Androgen-Pathway Agents (2)
Relugolix Monotherapy For Adt (2)
Ribociclib + Aromatase Inhibitor (1)
Ribociclib + Fulvestrant (1)
Rucaparib Monotherapy (4)
Sarcoma Regimens (1)
Secondary Prophylaxis (0)
Selected Combinations Under Disease-Specific Labels (0)
Selected Net/Rcc Regimens (4)
Selected Pancreatic Cancer Combination With Gemcitabine (5)
Selected Prostate Cancer Regimens (1)
Selected Prostate Cancer Use Where Labeled (4)
Sequential Endocrine Therapy (3)
Small-Cell Lung Cancer Regimens (2)
Stupp Regimen (Temozolomide + Radiotherapy) (3)
Sunitinib Monotherapy (6)
T-Dm1 Monotherapy (0)
T-Dxd Monotherapy (0)
Tamoxifen Monotherapy (1)
Tc (10)
Tch (6)
Tch/Tchp (16)
Tchp (6)
Tchp Does Not Contain Doxorubicin (1)
Thalidomide + Dexamethasone (0)
Thp (6)
Topotecan Monotherapy (0)
Trastuzumab + Endocrine Therapy (6)
Trastuzumab + Pertuzumab + Taxane (0)
Trastuzumab + Taxane (6)
Tucatinib + Trastuzumab + Capecitabine (0)
Uncategorized (0)
Venetoclax + Azacitidine/Decitabine (0)
Venetoclax + Obinutuzumab (0)
Venetoclax + Rituximab (0)
Vip (2)
Vrd (6)
Weekly Paclitaxel + Trastuzumab (5)
Shopping cart
Your cart is empty
Continue Shopping
0
Cart
All
5-Fu/Leucovorin (2)
6-Mp-Containing Pediatric All Protocols (1)
7+3 (1)
7+3 + Midostaurin (2)
Abiraterone + Androgen-Deprivation Therapy (Adt) (10)
Abiraterone + Prednisone/Prednisolone (10)
Abvd (1)
Abvd Alternatives (1)
Abvd Variants (1)
Ac (3)
Ac-T (7)
Acalabrutinib + Obinutuzumab (4)
Acalabrutinib + Venetoclax (4)
Acalabrutinib Monotherapy (4)
Adjuvant Abemaciclib + Endocrine Therapy (2)
Adjuvant Endocrine Therapy (5)
Adjuvant Ribociclib + Endocrine Therapy (1)
All Maintenance (1)
Alpelisib + Endocrine Therapy In Selected Breast Cancer Settings (1)
Alpelisib + Fulvestrant (1)
Anastrozole Monotherapy (3)
Androgen-Deprivation Regimens (2)
Apalutamide + Adt (1)
Apalutamide + Adt In Metastatic Hormone-Sensitive Disease (1)
Appetite-Supportive Care Protocols (3)
Atezolizumab + Bevacizumab (4)
Avelumab Maintenance After Platinum Chemotherapy In Urothelial Carcinoma (1)
Avelumab Monotherapy (1)
Azacitidine + Venetoclax (3)
Azacitidine Monotherapy (3)
Azacitidine-Based Aml/Mds Regimens (3)
Bendamustine + Rituximab (4)
Bendamustine + Rituximab (Br) (1)
Bendamustine-Based Lymphoma Regimens (1)
Bep (6)
Bicalutamide + Lhrh Agonist/Adt (1)
Bortezomib-Based Myeloma Regimens (3)
Braf-Targeted Colorectal Combinations (2)
Breast Cancer Anthracycline Regimens (1)
Cabozantinib Monotherapy (3)
Capecitabine + Oxaliplatin Or Other Disease-Specific Combinations (3)
Capox + Bevacizumab (3)
Capox/Xelox (7)
Carboplatin + Gemcitabine (6)
Carboplatin + Pemetrexed (6)
Carboplatin/Paclitaxel + Bevacizumab (4)
Carbotaxol (11)
Cetuximab + Radiation (2)
Chemoradiation (2)
Chemoradiation Regimens (4)
Chemotherapy + Dasatinib In Ph-Positive All (5)
Chemotherapy-Induced Nausea/Vomiting Prophylaxis (2)
Chop/R-Chop (3)
Cisplatin + Gemcitabine (4)
Cisplatin + Pemetrexed (4)
Cladribine Monotherapy (1)
Cmf (4)
Combination Antiemetic Regimens (2)
Combination Ar-Pathway Regimens (10)
Consolidation Regimens (1)
Consolidation/Maintenance-Related Flt3 Regimens (2)
Crizotinib Monotherapy (1)
Cybord (2)
Cybord/Vcd (3)
Cytoreduction Regimens (3)
Dacarbazine-Based Melanoma Regimens (1)
Dara-Rd (3)
Dara-Vrd (3)
Dasatinib Monotherapy (5)
Dhap (4)
Disease-Specific Regimens (1)
Docetaxel + Adt (5)
Docetaxel + Ramucirumab (5)
Ec/Ec-T (1)
Endocrine Combinations (2)
Endocrine Therapy + Abemaciclib (2)
Endocrine Therapy Combinations (3)
Ep (2)
Erlotinib Monotherapy (5)
Everolimus + Endocrine Therapy (4)
Everolimus + Exemestane (4)
Exemestane + Everolimus (1)
Exemestane Monotherapy (1)
Fec/Fec-T (1)
Flag-Ida (1)
Flag-Ida Variants (1)
Folfiri (2)
Folfiri + Bevacizumab (4)
Folfiri + Cetuximab (2)
Folfirinox (6)
Folfox (6)
Folfox + Bevacizumab (4)
Folfox + Cetuximab (2)
Folfox-Like Combinations Are Not Paclitaxel Regimens (5)
Folfox-Like Combinations Are Not Standard Cisplatin Regimens (4)
Fulvestrant + Alpelisib (4)
Fulvestrant + Cdk4/6 Inhibitor (4)
Fulvestrant + Targeted Agents (4)
Gastric/Gej Her2 Regimens (6)
Gefitinib Monotherapy (3)
Gemcis/Cisgem (2)
Gemcitabine + Carboplatin (2)
Gemcitabine + Docetaxel (2)
Gemcitabine + Nab-Paclitaxel (2)
Goserelin + Tamoxifen/Aromatase Inhibitor (2)
Hairy Cell Leukemia Regimens (1)
Hidac (1)
Historically Used Hormonal Therapy (1)
Hormonal Therapy (3)
Hydroxyurea Monotherapy (3)
Hyper-Cvad (1)
Hyper-Cvad And Many Hematologic Regimens (2)
Hyper-Cvad Variants (4)
Isa-Kd And Other Myeloma Combinations (1)
Kd (1)
Krd (1)
Lapatinib + Capecitabine (3)
Lapatinib + Trastuzumab (3)
Letrozole + Cdk4/6 Inhibitor (1)
Letrozole Monotherapy (1)
Leuprolide + Antiandrogen (2)
Leuprolide + Ar-Pathway Inhibitor (2)
Lymphoma Combinations (3)
Lymphoma/Leukemia Salvage (1)
Maintenance After Autologous Transplant (3)
Maintenance In Ovarian Cancer (4)
Maintenance Rituximab (4)
Maintenance Temozolomide (3)
Metastatic Hr+/Her2- Endocrine Combinations (2)
Mopp (1)
Nilotinib Monotherapy (2)
Nintedanib + Docetaxel (1)
Nivolumab + Cabozantinib (4)
Nivolumab + Chemotherapy (1)
Nivolumab + Ipilimumab (1)
Nivolumab + Relatlimab (1)
Not A Standard Contemporary First-Line Regimen In Most Major Guidelines (1)
Olaparib + Bevacizumab (7)
Olaparib + Endocrine Therapy In Selected Settings (7)
Olaparib Maintenance (7)
Older Combined Androgen Blockade Regimens (1)
Other Disease-Specific Combinations (4)
Other Disease-Specific Regimens (5)
Other Myeloma Combinations (6)
Ovarian Platinum Regimens (6)
Ovarian Suppression (2)
Ovarian Suppression + Tamoxifen (1)
Paclitaxel + Pembrolizumab (5)
Palbociclib + Fulvestrant (6)
Palbociclib + Letrozole (6)
Palbociclib + Trastuzumab ? Pertuzumab + Endocrine Therapy (6)
Pcv (1)
Platinum/Etoposide Regimens (2)
Pomalidomide + Daratumumab + Dexamethasone (6)
Pomalidomide + Dexamethasone (6)
R-Chop (4)
R-Chop Variants (3)
R-Cvp (4)
Radiotherapy-Induced Nausea Protocols (2)
Rd (3)
Regorafenib Monotherapy (2)
Relugolix + Androgen-Pathway Agents (2)
Relugolix Monotherapy For Adt (2)
Ribociclib + Aromatase Inhibitor (1)
Ribociclib + Fulvestrant (1)
Rucaparib Monotherapy (4)
Sarcoma Regimens (1)
Selected Net/Rcc Regimens (4)
Selected Pancreatic Cancer Combination With Gemcitabine (5)
Selected Prostate Cancer Regimens (1)
Selected Prostate Cancer Use Where Labeled (4)
Sequential Endocrine Therapy (3)
Small-Cell Lung Cancer Regimens (2)
Stupp Regimen (Temozolomide + Radiotherapy) (3)
Sunitinib Monotherapy (6)
Tamoxifen Monotherapy (1)
Tc (10)
Tch (6)
Tch/Tchp (16)
Tchp (6)
Tchp Does Not Contain Doxorubicin (1)
Thp (6)
Trastuzumab + Endocrine Therapy (6)
Trastuzumab + Taxane (6)
Vip (2)
Vrd (6)
Weekly Paclitaxel + Trastuzumab (5)
Login
Enter your username and password to login.
Remember me
Lost password?
Welcome to our online store!
Zmdi-facebook
Zmdi-twitter
Zmdi-youtube-play
Zmdi-instagram
0
0
₹
0.00
Your cart is empty
Continue Shopping
Home Medicine
Shop
Page
About Us
Contact Us
FAQs
Terms Of Use
Recently Viewed
You have no recent viewed item.
Shop
Home
Ovarian Suppression + Tamoxifen
Showing the single result
Default sorting
Sort by popularity
Sort by latest
Sort by price: low to high
Sort by price: high to low
-25%
Quick View
TAMTERO 20MG TABLET
₹
23.00
Current price is: ₹23.00.
₹
30.70
Original price was: ₹30.70.
Add to cart
